Previous 10 | Next 10 |
2024-02-11 18:00:00 ET Summary PTC Therapeutics has a diverse portfolio and pipeline of drugs, including a broader DMD treatment. The company has not fully expanded its revenue-generating products geographically and is in the process of making the necessary submissions to do so. ...
2024-01-31 00:21:00 ET Summary Q4 marks the end of a difficult year for Russell 2000 earnings. Energy is no longer the 'top dog' from an earnings growth contribution perspective. Financials has the largest earnings weight for the second consecutive quarter. By Taji...
2024-01-25 17:30:32 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript PTC Therapeutics says total unaudited FY23 net revenue was about $946M PTC Therapeutics issues EU, US regulatory updates on Translarna Seeking Alpha...
2024-01-25 16:59:42 ET Gainers: Ocular Therapeutix, ( OCUL ) +5% . AppFolio ( APPF ) +4% . Sagimet Biosciences ( SGMT ) +3% . Xcel Energy ( XEL ) +3% . Digital World Acquisition ( DWAC ) +2% . Losers...
CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure PR Newswire SOUTH PLAINFIELD, N.J. , Jan. 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) anno...
2024-01-08 11:40:25 ET More on PTC Therapeutics PTC Therapeutics issues EU, US regulatory updates on Translarna PTC Therapeutics stock slides after Citi downgrades to Sell Seeking Alpha’s Quant Rating on PTC Therapeutics Historical earnings data for PT...
PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire ...
PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire SOUTH PLAINFIELD, N.J. , Jan. 3, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the 42 n...
2023-12-23 05:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-05 17:53:48 ET More on PTC Therapeutics PTC Therapeutics, Inc. (PTCT) Q3 2023 Earnings Call Transcript PTC Therapeutics stock slides after Citi downgrades to Sell PTC Therapeutics GAAP EPS of -$1.76 misses by $0.70, revenue of $196.6M misses by $15.07M ...
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
2024-07-12 10:00:03 ET Jeffrey Hung from Morgan Stanley issued a price target of $32.00 for PTCT on 2024-07-12 08:15:00. The adjusted price target was set to $32.00. At the time of the announcement, PTCT was trading at $33.2. The overall price target consensus is at $43....
CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review PR Newswire - PTC to submit a request for re-examination - WARREN, N.J. , June 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announce...
Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients PR Newswire - FDA lifts PTC518 partial clinical hold based on PIVOT-HD data - - Conference call and webcast to be held ...